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Abstract
Background: Allergic sensitisation towards cashew nut of-
ten happens without a clear history of eating cashew nut. IgE 
cross-reactivity between cashew and pistachio nut is well 
described; however, the ability of cashew nut-specific IgE to 
cross-react to common tree nut species and other Anacar-
diaceae, like mango, pink peppercorn, or sumac is largely 
unknown. Objectives: Cashew nut allergic individuals may 
cross-react to foods that are phylogenetically related to ca-
shew. We aimed to determine IgE cross-sensitisation and 
cross-reactivity profiles in cashew nut-sensitised subjects, 
towards botanically related proteins of other Anacardiaceae 
family members and related tree nut species. Method: Sera 
from children with a suspected cashew nut allergy (n = 56) 
were assessed for IgE sensitisation to common tree nuts, 
mango, pink peppercorn, and sumac using dot blot tech-
nique. Allergen cross-reactivity patterns between Anacardi-
aceae species were subsequently examined by SDS-PAGE 
and immunoblot inhibition, and IgE-reactive allergens were 
identified by LC-MS/MS. Results: From the 56 subjects anal-
ysed, 36 were positive on dot blot for cashew nut (63%). Of 
these, 50% were mono-sensitised to cashew nuts, 19% were 
co-sensitised to Anacardiaceae species, and 31% were co-
sensitised to tree nuts. Subjects co-sensitised to Anacardia-
ceae species displayed a different allergen recognition pat-
tern than subjects sensitised to common tree nuts. In pink 
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peppercorn, putative albumin- and legumin-type seed stor-
age proteins were found to cross-react with serum of cashew 
nut-sensitised subjects in vitro. In addition, a putative lumi-
nal binding protein was identified, which, among others, 
may be involved in cross-reactivity between several Anacar-
diaceae species. Conclusions: Results demonstrate the in vi-
tro presence of IgE cross-sensitisation in children towards 
multiple Anacardiaceae species. In this study, putative novel 
allergens were identified in cashew, pistachio, and pink pep-
percorn, which may pose factors that underlie the observed 
cross-sensitivity to these species. The clinical relevance of 
this widespread cross-sensitisation is unknown.
© 2018 The Author(s) 
Published by S. Karger AG, Basel
Introduction
Cashew nut allergy has been recognised as a severe tree 
nut allergy amongst (Dutch) children and young adults 
[1–3], and its prevalence seems to be increasing [4, 5]. 
Often, young children suffer from a cashew nut allergy 
without a clear history of cashew nut consumption [3]. 
This raises the question whether cashew nut allergy man-
ifests from a primary sensitisation or is caused by cross-
sensitisation to botanically related or unrelated foods.
Cashew belongs to the family of Anacardiaceae, cate-
gorised under the taxonomic class of Magnoliopsida to 
which most common tree nuts belong, as depicted in Fig-
ure 1. Several studies have shown that a tree nut-allergic 
patient has considerable chance of being sensitised (86%) 
[6] or allergic to multiple tree nuts (35–37% based on 
clinical history [7, 8] and 14–47% based on food chal-
lenges [6, 9]). The underlying reason is thought to be the 
major sequential and structural homology between the 
highly abundant seed storage proteins (glycinins, vicilins, 
and 2S albumins) and to a lesser extent the defence-relat-
ed proteins (nsLTP, chitinases, and PR-10 proteins, e.g. 
Bet v 1 homologues) and pan allergens (profilin and hev-
ein-related proteins) present in tree nuts and other bo-
tanically related foods [10, 11].
Cross-sensitisation between cashew and other tree 
nuts, such as hazelnut and walnut has been reported at 
IgE level [12–15] as well as at T-cell level [16, 17] where 
mostly Ana o 1 and Ana o 2 acted as cross-reacting aller-
gens [16]. Amongst Anacardiaceae members, allergic 
cross-reactivity between pistachio and cashew nut is well 
recognised [12, 15, 18–21] and avoidance of both nuts is 
advised in case of a confirmed cashew nut allergy [22]. 
The strong phylogenetic relationship between cashew 
and pistachio nut is reflected by the high amino acid sim-
ilarity and conserved three-dimensional regions between 
the cashew nut and pistachio seed storage allergens Ana 
o 1/Pis v 3 (7S vicilin), Ana o 2/Pis v 2 (11S legumin), and 
Ana o 3/Pis v 1 (2S albumin) with a similarity of 78, 80, 
and 70%, respectively [15, 20, 23].
Mango, pink peppercorn (often included in pepper-
corn blends and seasoning mixes), and the Middle East-
ern spice sumac are also phylogenetically classified as 
Anacardiaceae. Recent case reports describing the inci-
dence of cashew nut-allergic patients experiencing ana-
phylaxis after consumption of pink peppercorn or sumac 
emphasise the potential risk of cross-reactivity among 
different members of the Anacardiaceae family [24, 25]. 
Mango has shown to be an important cross-reacting food 
for patients suffering from the “celery-mugwort-spice 
syndrome” and “latex-fruit syndrome” [26], partly caused 
by the Bet v 1 and 2-like type allergens [27–30]. However, 
mango-cashew nut cross-sensitisation seems to be of less 
clinical relevance as only few cases have been reported of 
mango allergic individuals co-sensitised to pistachio [31] 
or cashew apple fruit [32]. Although such findings sug-
gest the presence of potentially cross-sensitising and 
cross-reacting proteins between different members of the 
Anacardiaceae, no (cross-reactive) allergenic proteins for 
pink peppercorn, mango, or sumac have been identified 
as yet. Moreover, widespread cross-sensitisation in pa-
tients to these related allergens without prior consump-
tion, makes identification of the primary sensitising agent 
extremely difficult.
Therefore, the aim of the present study was (1) to vi-
sualise co-sensitisation patterns (i.e., presence of specific 
IgE antibodies (sIgE) towards mango, pink peppercorn, 
sumac, and related tree nuts) in serum of children sus-
pected of a cashew nut allergy, and (2) to examine the al-
lergenic cross-reactivity of cashew nut proteins present in 
pistachio, mango, and pink peppercorn by means of im-
munoblot inhibition assays in order to study the associ-
ated IgE binding affinity of cashew nut allergens towards 
multiple anacardiaceous species.
Materials and Methods
Materials and Reagents
Patient Serum 
In total, 176 patients with a suspected cashew nut allergy (sen-
sitised in combination with either a positive history or never eaten 
before) participated in the multi-centre prospective study “Im-
provement of Diagnostic mEthods for ALlergy assessment” with 
cashew allergy in children as a showcase (IDEAL study) with trial 
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number NTR3572. A subset of 56 sera from children (between 2 
and 17 years old) included in the study at Erasmus MC Rotterdam, 
with sufficient serum for further research analysis, were selected 
for additional investigations. Patient medical profiles, including 
results from Siemens IMMULITE 2000 XPi Immunoassay serum 
IgE measurements, skin prick tests (SPTs), and cashew nut-fo-
cused double-blind placebo-controlled food challenges (DBPCF-
Cs) were gathered from the existing published IDEAL database [3].
Nuts, Consumables, and Reagents
For this study, members of the Anacardiaceae family (cashew 
nut, pistachio, mango, pink peppercorn, and sumac) and nuts 
from other families (pine nut, Brazil nut, chestnut, hazelnut, pecan 
nut, walnut, macadamia, and almond) were investigated (Fig. 1). 
All nuts, except pine nuts and macadamia nuts, were purchased 
raw in shell, to avoid allergen cross-contamination that might oth-
erwise occur during the retail phase. Raw pine nuts (Take One, 
Rotterdam, the Netherlands) and dry roasted macadamia nuts 
(Horizon Natuurvoeding BV, IJsselstein, the Netherlands) were 
purchased as peeled nuts. Cashew nut, pistachio, and walnut as 
well as ground sumac (Nergiz Grossmarkt GmbH, Gronau, Ger-
many) were kindly provided by Intersnack BV (Doetinchem, The 
Netherlands). Pink peppercorn kernels were from Fuchs Gewürze 
GmbH (Dissen, Germany). Mango fruit and all other nuts were 
purchased at the local supermarket. Consumables, chemicals, and 
reagents, except where stated otherwise, were obtained from Sigma 
Aldrich (St. Louis, USA).
Dot Blot Immunoassays
Total Protein Extraction
Depending on the size and availability of shelled nuts, 3–30 
nuts were cut in small pieces using a single-use cutting board and 
knife and mixed to obtain a representative sample batch for each 
type of nut. In case of mango, the peel and flesh of the fruit were 
cut into little pieces followed by immediate acetone extraction (1: 
2.5 w/v) at 4  ° C for 2 h while stirring in order to deplete excess 
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Fig. 1. Phylogenetic classification of Anacardiaceae family mem-
bers in accordance to other tree nuts: almond (Prunus dulcis), Bra-
zil nut (Bertholletia excelsa), cashew (Anacardium accidentale), 
chestnut (genus Castanea), hazelnut (genus Corylus), macademia 
(genus Macademia), mango (genus Magnifera), pecan (Carya il-
linoinensis), pine nut (Pinus koraiensis), pink peppercorn (Schinus 
terebinthifolia/molle), pistachio (Pistacia vera), sumac (genus 
Rhus), and walnut (Juglans regia). Taxonomic data were obtained 
from plants.usda.gov. Photos are from Shutterstock.
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amounts of pectin. After filtration (Whatman 595 1/2, Dassel, Ger-
many), the acetone extraction was repeated, and the mango pieces 
were subsequently dried overnight and stored at 4  ° C. Dried berries 
were used in its entirety (pink peppercorn) or powdered (sumac).
Of each nut, seed, and fruit sample, two protein extracts were 
prepared: a denatured extract in urea/phosphate buffer and a non-
denatured extract in Tris buffer. The urea/phosphate extracts were 
prepared by homogenising 0.5 g of sample in 10 mL of buffer (20 
mM sodium phosphate pH 7; 1 mM NaCl; 8 M urea) as described 
by Burks et al. [33] using an Ultra-Turrax (IKA, Staufen, Germa-
ny) and incubating o/n at 4  ° C under continued stirring. Protein 
extracts were obtained by centrifugation and stored at 4  ° C until 
further use. The Tris extracts were prepared by homogenising 1 g 
of sample in 10 mL Tris buffer (20 mM Tris pH 7.6; 150 mM NaCl; 
1 mM EDTA) [34] using the same procedure as described for the 
urea/phosphate buffer. The same extraction procedures were ap-
plied for pink peppercorn and sumac, except that 2.5 and 5 g of 
sample was used per urea/phosphate or Tris buffer, respectively. 
In case of mango, 5 g of the acetone-extracted peel and flesh was 
used per extraction buffer.
In between extractions, the Ultra-Turrax dispersing element 
was disassembled, and parts were incubated for 15 min in 1 M 
NaOH followed by a rinsing step in distilled water to clean the in- 
and outside from any residual protein to avoid allergen carry-over 
between extractions.
Protein Quantification
Protein concentration of each extract was determined by Brad-
ford assay (Thermo Fisher Scientific Inc., Rockford, IL, USA) ac-
cording to the manufacturers’ instructions. To ensure equal spot-
ting on dot blot, the concentration of each protein fraction as de-
termined by Bradford was verified by colloidal gold staining of 0.5 
µL droplets (500 ng/L) spotted in duplicate on 0.2-μm Protran BA 
83 nitrocellulose membranes (Whatman, Dassel, Germany) placed 
on a polyester backbone (GL Precision, San Jose, CA, USA). Den-
sitometric analyses were performed using a Universal Hood III 
and Image Lab 4.1 software (both Bio-Rad, Hercules, CA, USA) 
and concentrations were adjusted when necessary.
Dot Blot Assay
To obtain a representative protein extract, equal amounts of the 
urea/phosphate fraction and Tris fraction were mixed to a final 
concentration of 500 ng/µL. Subsequently, 250 ng was spotted in 
duplicate on a 35 × 6 mm (L × W) square strip of 0.2-μm nitrocel-
lulose membrane placed on a polyester backbone. Each strip was 
then dried for 1 h at 37  ° C and stored at room temperature in the 
dark for up to 1 week. Per patient, one strip was used to analyse the 
IgE reactivity to the different nuts, seeds, and mango protein frac-
tions using the dot blot technique as described earlier [35]. A max-
imum of 10 patients’ sera were screened per handling, every time 
taking along an antibody background control strip incubated with 
TBS buffer instead of patient serum. Spot intensities after 5 min of 
staining were analysed using a Universal Hood III and Image Lab 
4.1 software. Non-specific antibody staining as measured on the 
control strips were subtracted from the patient serum strips per 
spot per screening batch.
Spot intensity = mean (spot1serum – spotcontrol, spot2serum –  
spotcontrol)
IgE Sensitisation towards Cross-Reactive Carbohydrate 
Determinants
Cashew total protein extract (Tris:urea/phosphate; 1: 1), bro-
melain from pineapple stem (B5144), and ascorbate oxidase from 
Cucurbita sp. (A0157) were spotted in duplicate and incubated 
with TBS or serum pool of patient group III (group description is 
clarified in Table 1) as described above. Serum of patient group I 
was not evaluated for CCD sensitisation due to limitation in serum 
quantity.
Western Blot Immunoassays
Patient Selection
Patient groups I and III (Table 1) were chosen for further selec-
tive investigations, as these groups showed specifically in vitro co-
sensitisation to multiple Anacardiaceae species. As some of the 
serum samples were low in volume, consequently, only a part of 
the sera per group could be used for further investigations, and the 
number of immunoblotting experiments that could be performed 
was limited even when sera were pooled.
SDS PAGE and Western Blotting
SDS PAGE (denatured and reduced) and Western blotting of 
cashew nut, pistachio, mango, and pink peppercorn protein frac-
tions were performed as described by Reitsma et al. [36]. Sumac 
extracts smeared heavily on SDS PAGE (data not shown) and were 
therefore excluded from further immunoblot experiments. Tris 
and urea/phosphate extracted protein fractions mixed 1: 1 (w/w; 15 
µg in total per lane), were separated by SDS-PAGE on NuPage 10% 
BIS/TRIS gels according to the manufacturer’s instructions (Invi-
trogen, Carlsbad, CA, USA) and either stained by Simply Blue safe 
stain (Thermo Fisher Scientific Inc., Rockford, IL, USA) or trans-
ferred to a 0.2-μm nitrocellulose membrane (LKB, Bromma, Swe-
den).
For Western blotting, membranes were either incubated in sera 
selected from patient group I (6 out of 7 were used: patient No. 27, 
30, 39, 49, 55, and 62; pooled equal in volumes) or sera selected 
from patient group III (6 out of 11 sera were used: patient No. 5, 
15, 53, 54, 58, and 63; pooled equal in volumes). Membranes incu-
bated in TBS buffer without serum were used as an antibody back-
Table 1. Post hoc analysis (i.e., analysis criteria that were not spec-
ified before seeing the data) used to classify patient sera into sen-
sitization groups I–IV according to dot blot spot intensity results 
(Fig. 3)
Group Particulars
I Positive for cashew; positive for ≥1 other member 
within the Anacardiaceae family; positive for ≤1 nut 
outside the family of Anacardiaceae
II Positive for cashew, but negative for other members of 
the Anacardiaceae family, positive for ≤2 nuts outside 
the family of Anacardiaceae
III Positive for cashew and ≥1 other member within the 
Anacardiaceae family; positive for ≥2 nuts outside the 
family of Anacardiaceae
IV Negative for cashew
IgE Cross-Reactivity of Anacardiaceae 
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ground control. Immunolocalisation of ribulose and luminal bind-
ing protein (BiP) was performed as described above, using a rabbit 
anti-RuBisCo polyclonal antibody (MBS715138; 1: 2,000) from 
Spinacia oleracea (MyBioSource Inc., San Diego, CA, USA) and a 
rabbit anti-luminal BiP (BiP2; AS09 481; 1: 2,000) polyclonal anti-
body from Arabidopsis thaliana (Agrisera AB, Vännas, Sweden) 
according to the manufacturer’s instructions. An alkaline phos-
phatase-conjugated goat anti-rabbit polyclonal secondary anti-
body (A3687; 1: 20,000) and NBT/BCIP staining were used for vi-
sualisation.
Western blot inhibition assays were performed as described 
above, except that the serum pools used were preincubated with 
1 mg/ml cashew protein (Tris and urea/phosphate fractions 1: 1) 
for 2.5 h at room temperature prior to incubation with nitrocel-
lulose membrane. Blots were stained for 7 min (Western blots) or 
20 min (inhibition blots).
Protein Identification
IgE reactive protein bands as visualised by Western blotting 
were excised from corresponding Simply Blue safe stained SDS 
PAGE gels. Protein identification by LC-MS/MS was performed as 
described by Reitsma et al. [36] with the following minor adjust-
ments: the 5 most intense peaks with charge state 2–4 in the full 
MS scans were fragmented in a HCD collision cell with a nor-
malised collision energy of 28%. Further, the lower MS2 mass was 
set to 140 with automatic maximum and a mass resolution of 
17,500 (at m/z 200).
LC-MS/MS data acquired by the Q-Exactive were processed 
using ProteomeDiscoverer software 1.4 (Thermo Scientific). The 
obtained fragmentation spectra were searched against a protein 
database using Sequest HT with precursor mass tolerance of 10 
ppm and fragment mass tolerance of 20 mDa. The database, down-
loaded on February 2, 2015, from the NCBI, contained all available 
protein sequences known for: Anacardiaceae (containing cashew 
nut family species), Arachis hypogaea (peanut), Bertholletia (con-
taining Brazil nut species), Carya illinoinensis (pecan), Castanea 
(containing chestnut species), Corylus (containing hazelnut spe-
cies), Corylus avellana (European hazelnut), Juglans (containing 
walnut species), Macadamia (containing macadamia nut species), 
Mangifera (containing mango species), Pinaceae pinus (pine nut), 
Prunus dulcis (almond), and the order of Sapindales.
Raw LC-MS/MS processing data were pre-screened, removing 
unlikely protein matches such as human keratin, peptides showing 
a poor peak pattern, as well as intense protein bands retrieving low 
numbers of matched peptides. Final results are presented in Table 
3. As only the 5 most intense mass peaks were used for LC-MS/MS 
analysis, we prioritised high abundant proteins over lower abun-
dant proteins of comparable size present in the excised bands.
Statistics
Correlation coefficients (R) between dot blot sIgE, IMMULITE 
sIgE, and SPT results were calculated by Excel using the Pearson 
correlation formula:
ρx, y = Cov (X,Y)/(σx  •  σy)
The standard variation of medians (σ) was calculated by mul-
tiplying the median absolute deviation (MAD) by the normal me-
dian distribution factor 1.483 in Excel using the formula:
σ = 1.483 MAD
Significance between group medians was evaluated by the 
Kruskal-Wallis one-way analysis of variance test using Genstat 
18th edition. Groups with a χ2 probability (p value) below 0.05 
were considered to not have equal medians.
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Fig. 2. Correlations between dot blot sIgE measurements and clinical sIgE (IMMULITE) and SPT measurements 
for cashew, pistachio, and mango in all patients. Clinical sIgE/sSPT data are displayed as relative IgE/SPT on the 
y axis. Relative dot blot sIgE (DSI) is displayed on the x axis. The correlation coefficient R, the degree of linear 
correlation between the two variables X and Y, is indicated for each plot.
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Results
IgE Sensitisation Profiles of Patient Sera
Fifty-six children with a suspected cashew nut allergy 
(e.g., sensitised to cashew either in IgE and/or SPT [3], 
who have participated in the IDEAL study, were without 
pre-knowledge of DBPCFC outcome assessed for IgE 
sensitisation to other members of the Anacardiaceae fam-
ily (pistachio, mango, pink peppercorn, and sumac) and 
members of the tree nut family (almond, Brazil nut, chest-
nut, hazelnut, macadamia, pecan, pine nut, and walnut) 
using dot blot immunoassays to evaluate sensitisation 
profiles. When comparing both types of sIgE binding 
measurements for the Anacardiaceae species, high cor-
relations between dot blot and IMMULITE sIgE were 
seen for both cashew nut (R = 0.84) and pistachio (R = 
0.75) but not for mango (Fig. 2). In contrast, no signifi-
cant correlation was observed between dot blot sIgE and 
positive SPT results (R = 0.29 and R = 0.13 for cashew nut 
and pistachio, respectively).
Interestingly, based on relative dot blot spot intensities 
of IgE-reactive protein spots and post hoc analysis of sIgE 
binding patterns, we were able to classify patients into 
four different groups according to their sensitisation pro-
files (Fig. 3): group I, patients that showed co-sensitisa-
tion profiles towards only Anacardiaceae species; group 
II, patient reacting to proteins extracted from cashew nuts 
but not to proteins from other Anacardiaceae; group III, 
patients that reacted to several different tree nuts and to 
Anacardiaceae species; and in group IV, patients that did 
not respond to cashew nut protein on dot blot. Details of 
the post hoc analysis are specified in Table 1.
All 7 patients displaying a group I profile showed a 
clinically relevant cashew nut sensitisation (positive DB-
PCFC) as specified in Table 2. Group II contained 18 
members. Within these 18 patients, 4 patients (22%) dis-
played a clinically non-relevant cashew nut sensitisation 
based on a negative DBPCFC test outcome. Eleven pa-
tients showed sensitisation against almost all protein frac-
tions tested (group III members). Three patients (28%) 
Table 2. Characteristics of patients classified into groups I–IV according to dot blot [3]
Group I II III IV
Patients, n 7 (13%) 18 (32%) 11 (20%) 20 (36%)
Male gender 5 (71%) 7 (39%) 7 (64%) 10 (50%)
Mean age, years 7.7 (3–13) 7.9 (2–13) 8.2 (3–14) 9.3 (2–17)
Atopic disease symptoms
Asthma 3 (43%) 94 (25%) 7 (65%) 8 (40%)
Eczema 4 (57%) 9 (50%) 7 (64%) 13 (65%)
Hay fever 2 (29%) 5 (28%) 7 (64%) 10 (50%)
Atopy 5 (71%) 11 (61%) 11 (100%) 14 (70%)
Median sIgE cashew nut, kU/L (σ)* 27.0 (26.2)a 7.5 (6.5)b 22.1 (29.0)a 0.9 (0.7)c
Median SPT cashew nut HEP (σ) 3.2 (2.7)a 2.6 (2.0)a 2.7 (2.6)a 2.0 (2.1)a
Outcome of DBPCFC test
Positive 7 (100%) 14 (78%) 8 (72%) 12 (60%)
Negative 0 4 (22%) 3 (28%) 7 (35%)
Undetermined 0 0 0 1 (5%)
sIgE, specific IgE; SPT, skin prick test; DBPCFC, double-blind placebo-controlled food challenge; HEP, histamine equivalent prick 
index area; *, as measured by Immulite; σ, standard deviation of the medians. Superscript letters indicate significant differences between 
group medians, p < 0.05.
Fig. 3. Relative dot blot spot intensities in relation to correspond-
ing IgE (Siemens IMMULITE), SPT, and DBPCFC data per patient 
and classification into groups (I–IV). Per group, the median IgE 
and SPT values are indicated below the lines. Patient numbers cor-
respond to the last two digits in the patient ID series 1110001 until 
1110079 in the IDEAL study by Van der Valk et al. [3]. Colours 
were used to differentiate in spot intensity (–, +/–, and + until 
+++): light orange < 1.27; salmon 1.27–1.3; yellow/orange 1.3–1.5; 
orange 1.5–2; brown > 2. Examples of a dot blot for each patient 
group are shown to the right. An antibody control blot shows any 
non-specific background staining used for data normalisation. 
The dot blot spot layout indicates the location of each protein sam-
ple on the nitrocellulose membranes: (1) walnut, (2) cashew, (3) 
pistachio, (4) sumac, (5) macadamia, (6) almond, (7) Brazil nut, 
(8) pecan, (9) chestnut, (10) mango, (11) pink peppercorn, (12) 
pine nut, (13) hazelnut.
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within this group tested negative in DBPCFCs. All group 
III children suffer from atopy and disease symptoms as 
asthma and hay fever which are twice as frequent within 
this patient group in comparison to group I, which might 
be reflected in the dot blot sensitisation profile (sensitisa-
tion towards multiple botanically semi-related foods). 
Twenty patients (group IV) showed no sIgE-binding ac-
tivity to cashew nut extract on dot blot. As specified by 
van der Valk et al. [3], 7 patients of this group were also 
negative in the DBPCFC with cashew nut, and for 1 pa-
tient the DBPCFC-outcome was undetermined. Group 
IV also showed the lowest median sensitisation grade in 
IMMULITE sIgE for cashew nut (0.9 kU/L) and SPT (2.0 
HEP index area). In contrast, median cashew nut sIgE as 
measured by IMMULITE was highest in group I (27.0 
kU/L) and group III (22.1 kU/L) patients.
Based on the results above, we hypothesise that cashew 
nut allergic individuals might have a high chance of being 
co-sensitised to other nuts, seeds, or fruits and that differ-
ences in sensitisation profiles can be visualised by dot blot 
immunoassays.
Group-Specific Allergen Profiles Visualised by Western 
Blotting
Next, we aimed to identify the putative allergens un-
derlying the cross-sensitisation profiles of patient groups 
I and III. Group-specific allergen profiles were visualised 
by Western blotting using pooled serum from patient 
groups I and III separately, as depicted in Figure 4. Be-
cause of the limited amounts of patient serum, the immu-
noblot analyses were focused on the specific Anacardia-
ceae family members (cashew, pistachio, mango, and 
pink peppercorn).
In both groups, patients showed IgE co-sensitisation 
to protein extracts from pistachio, mango, and pink pep-
percorn (Fig.  4a–d). An antibody control blot revealed 
that only some unspecific background binding occurred 
to the mango protein fraction (Fig.  4d). Interestingly, 
group I and III patients displayed contrasting IgE sensiti-
sation patterns. As expected from results observed by dot 
blot, group III patients showed IgE sensitisation to many 
different bands in all protein fractions while group I pa-
tients only to a few protein bands. Protein bands repre-
senting 11S globulins, albeit recognised differently by 
each patient group, were identified in cashew nut (Ana o 
2, excised bands 2–5), pistachio (Pis v 2 and Pis v 5, ex-
cised bands 11, 12, 14, and 15), and pink peppercorn (ex-
cised bands 23, 25, and 26). The 7S vicilin allergen Ana o 
1 in cashew nut was not identified in any of the blots, 
which was already noted in earlier research by Reitsma et 
al. [36] using serum from the IDEAL patient cohort. Pis 
v 3, the 7S vicilin allergen in pistachio was however iden-
tified in excised bands 9. Also, the 2S albumins, cashew 
nut allergen Ana o 3 and Pis v 1 in pistachio, represented 
in bands 6 and 16 respectively, were recognised by both 
patient groups.
In addition to the already known cashew nut seed stor-
age allergens, putative novel cross-reactive Anacardiace-
ae allergens were identified. Protein bands of ca. 54 and 
73 kDa (excised bands 2, 8, 22 and 1, 7, respectively) spe-
cifically visualised by serum of group I patients in all nut/
seed protein fractions, were tentatively identified as ribu-
lose-1,5-bisphosphate carboxylase oxygenase and lumi-
nal BiP, respectively (Table 3). The observed location and 
identity of these IgE reactive proteins on SDS PAGE were 
confirmed using specific antibodies (Fig. 4i–k). In pink 
peppercorn, a putative 2S albumin allergen ca. 8 kDa in 
size was identified in excised band 28.
Although only minor IgE reactivity towards mango 
was observed on dot blot (Fig.  3), a clear reactivity on 
Western blot was observed by both group I and III to-
wards several chitinases and β-1,3-glucanases (excised 
bands 17–21) present in the mango protein fraction. 
Some non-specific binding towards the chitinase bands 
20 and 21 was observed in the control blot of which the 
exact cause is unclear. Nevertheless, the corresponding 
bands in Figure 4c, d were clearly higher in intensity, in-
dicating additional IgE-specific binding activity.
Immunoblot Inhibition by Cashew Nut Protein
The in vitro sIgE cross-reactivity to allergen extracts 
from the Anacardiaceae family in both serum pools from 
patient groups I and III was determined by pre-incubat-
Fig. 4. SDS PAGE (a), Western blots (b–d, i–k), and Western in-
hibition blots (e–h) of cashew (C), pistachio (P), mango (M), and 
pink peppercorn (PP) protein fractions. a SDS PAGE Coomassie 
staining. b Western blot using a serum pool of patient group I. c 
Western blot using a serum pool of patient group III. d Western 
blot control using TBS. e Reversible staining after nitrocellulose 
transfer. f Western blot using patient group I serum inhibited with 
cashew protein extract. g Western blot using patient group III se-
rum inhibited with cashew protein extract. h Western blot control 
using TBS inhibited with cashew protein extract. i Reversible stain-
ing after nitrocellulose transfer, j Western blot using an anti-lumi-
nal binding protein antibody. k Western blot using an anti-rubisco 
antibody. Numbers correspond to excised bands used for LC-MS/
MS protein identification as depicted in Table 2. f, g Asterisks in-
dicate protein bands still faintly visible on the inhibition Western 
blots. j, k Arrows in Western blots point out the luminal binding 
protein bands (arrow a) and rubisco protein bands (arrow b).
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Table 3. Identification of IgE-reactive proteins in excised bands using LC-MS/MS
Band
No.
Matching protein Western blot analysis LC-MS/MS analysis
serum
pool No.
mass, kDa accession E-score calc. mass, kDa uniq.
pept., 
n
sequence 
coverage, 
%
Cashew nut total protein extract
1 Luminal binding protein (Ca) 1 73 CAC14168 7.5e–9 73.6 25 35
2 Ribulose partial (Ao) 1 54 AAS79700 2.5e–9 51.6 3 42
11S globulin Ana o 2 (Ao) AAN76862 1.3e–9 52.0 34 78
3 11S globulin Ana o 2 (Ao) 1/3 32 AAN76862 3.3e–10 30 LS 43 86
4 11S globulin Ana o 2 (Ao) 1 21 AAN76862 6.5e–10 21 SS 43 77
5 11S globulin Ana o 2 (Ao) 1/3 19 AAN76862 1.5e–9 21 SS 29 66
11S globulin Pis v 2.0201 (Pv) ABG73110 2.3e–9 17–20 SS [15] 4 23
6 2S albumin Ana o 3 (Ao) 1/3 8 AAL91665 6.0e–9 8 LS 10 40
Pistachio total protein extract
7 Luminal binding protein (Ca) 1 76 CAC14168 1.1e–9 73.6 18 25
8 Ribulose partial (Pc) 1 54 CBI68284 1.5e–10 50.8 36 66
9 7S vicilin, partical, Pis v 3 (Pv) 3 41 ABO36677 4.4e–9 59.8 (45 on SDS) [14] 37 58 
10 7S vicilin, partical, Pis v 3 (Pv) 3 34 ABO36677 6.5e–10 59.8 (38 on SDS) [14] 28 44
11 11S globulin Pis v 5.0101 (Pv) 3 32 ACB55490 3.3e–10 30–40 LS [15] 39 87
11S globulin Pis v 2.0201 (Pv) ABG73110 3.6e–9 30–40 LS [15] 19 72
12 11S globulin Pis v 2.0101 (Pv) 3 29 ABG73109 1.8e–10 30–40 LS [15] 27 73
11S globulin Pis v 5.0101 (Pv) ACB55490 1.9e–10 30–40 LS [15] 33 82
13 Unknown 3 26 – – – – –
14 11S globulin Pis v 2.0201 (Pv) 1 19 ABG73110 6.4e–10 17–20 SS [15] 24 76
11S globulin Pis v 5.0101 (Pv) ACB55490 4.6e–9 30–40 SS [15] 19 58
15 11S globulin Pis v 2.0201 (Pv) 3 18 ABG73110 5.0e–9 17–20 SS [15] 23 73
11S globulin Pis v 5.0101 (Pv) ACB55490 1.6e–9 13–24 SS [15] 22 53
16 2S albumin Pis v 1 (Pv) 1/3 9 ABG73108 2.2e–10 17.3/(7 on SDS) [37] 18 50
Mango total protein extract
17 Chitinase partial (Mi) 3 42 ACD69683 9.8e–8 20, 25.5, 46, 50, 75 [38] 10 49
18 Chitinase partial (Mi) 3 35 ACD69683 1.1e–9 See band 17 12 65
β-1,3-glucanase (Mi) ABD16200 1.8e–9 19.5, 33-36, 42-46 [39] 10 64 
19 β-1,3-glucanase (Mi) 1/? 33 ABD16200 7.8e–10 See band 18 13 65
Chitinase partial (Mi) ACD69683 1.3e–9 See band 17 12 65
20 Chitinase partial (Mi) 1/3 27 ACD69683 5.7e–10 See band 17 20 87
21 Chitinase partial (Mi) 1/3 25 ACD69683 1.5e–9 See band 17 12 53
β-1,3-glucanase (Mi) ABD16200 2.7e–8 See band 18 9 60 
Pink pepper total protein extract
22 Ribulose (La) 1/? 52 AEB65826 1.4e–9 51.2 5 51
23 11S globulin Pis v 2.0201 (Pv) 3 42 ABG73110 4.6e–8 30–40 LS [15] 8 43
11S globulin Pis v 5.0101 (Pv) ACB55490 5.7e–8 30–40 LS [15] 4 12
24 Unknown 3 35 – – – – –
25 Hypothetical protein partial (Pt) 3 29 AEW08142 3.9e–8 16.3 1 52
11S globulin Pis v 2.0201 (Pv) ABG73110 3.7e–8 30–40 LS [15] 3 27
26 11S globulin Pis v 2.0201 (Pv) 3 19 ABG73110 2.8e–10 17–20 SS [15] 12 47
11S globulin Pis v 5.0101 (Pv) ACB55490 1.3e–10 13–24 SS [15] 5 14
27 ADP ribosylation factor (Ah) 3 17 AEV66152 7.4e–8 20.7 10 62
28 2S albumin Ana o 3 (Ao) 1/? 8 AAL91665 1.0e–8 8 LS 4 27
Binomial species nomenclature abbreviations: Ao, Anacardium occidentale; Ah, Arachis hypogaea; Ca, Corylus avellana; La, Loxosty-
lis alata; Mi, Mangifera indica; Pt, Pinus taeda; Pc, Pistacia chinensis; and Pv, Pistacia vera. LS, large subunit; SS, small subunit; uniq. 
pept., number of unique peptides.
IgE Cross-Reactivity of Anacardiaceae 
Allergens
11Int Arch Allergy Immunol
DOI: 10.1159/000493100
ing the serum pools with cashew nut protein extract prior 
to immunoblotting. Cashew nut protein was able to in-
hibit IgE immunostaining almost completely in all frac-
tions, including the mango fraction (Fig.  4e–h). This 
finding suggests that cashew nut is most likely the pri-
mary sensitiser in these patients.
Sensitisation to CCDs
Complete immunoblot inhibition of the mango IgE-
reactive chitinase and β-1,3-glucanase bands by cashew 
nut extract was rather unexpected as for cashew nut, these 
types of proteins have not been shown to be allergenic. 
IgE cross-reactivity between non-homologous and non-
related allergens, such as observed for cashew nut and 
mango, can in some cases be explained by antigenic cross-
reactive carbohydrate determinants (CCD) on glycopro-
teins which can affect in vitro allergy diagnosis. Patients 
within group III displayed IgE reactivity to bromelain and 
ascorbate oxidase (Fig.  5), two well-known CCD-con-
taining glycoproteins. This might partly explain the ex-
tensive immunoblot inhibition results observed in Figure 
4f, g.
Discussion
In this study, we demonstrated different IgE sensitisa-
tion profiles in the sera of 56 children with a suspected 
cashew nut allergy towards Anacardiaceae members and 
common tree nut species using dot blot immunoassays. 
Some patients (12.5%) in this subpopulation, with cashew 
protein-binding sIgE as shown on dot blot, demonstrated 
negative DBPCFCs [3] as depicted in Figure 3. This sug-
gests a clinically non-relevant IgE sensitisation to cashew 
nut protein. Also, patients with a positive DBPCFC but 
negative dot blot reactivity were observed (21.4%; IgE 
sensitisation profile IV, for details see next paragraph). As 
IMMULITE read-outs confirmed the presence of ca-
shew-sIgE in all of these patients, the protein extractabil-
ity for some of the cashew nut allergens might not have 
been optimal in the Tris and urea/phosphate buffers used 
in our study, or the applied dot blot technique was insuf-
ficiently sensitive. Possibly, the choice of raw cashew nuts 
in this study in contrast to the use of roasted cashew nuts 
in the original IDEAL study explains some of the discrep-
ancies. One might speculate that heat-labile allergens are 
not picked up by a DBPCFC using cashew-containing 
muffins. On the other hand, the generation of possible 
neoallergens [40, 41] or novel IgE-binding epitopes (as 
observed in roasted peanut) [42–44] as a result of the 
Maillard reaction during the heating process of cashews 
might provoke allergic symptoms in certain patients, 
while proteins from raw nuts might not. However, as ca-
shews are usually consumed blanched or roasted, the 
chance that some patients are primarily susceptible to raw 
cashew nuts, is very small.
Based on the dot blot spot intensity profiles, four dif-
ferent IgE sensitisation profiles (I–IV) could be distin-
guished, and patients were grouped accordingly. To our 
knowledge, this is the first study showing that specific 
sensitisation profiles can be identified using this immu-
noblot technique. Notably, 19% of patients tested (classi-
fied as group III patients) displayed IgE sensitisation to-
wards almost all protein fractions tested. For children, it 
is not unusual to be sensitised to multiple nut species such 
as in these group III patients, where not all sensitisations 
necessarily result in clinical symptoms [45]. The low sen-
sitisation profiles for some of the patients in the negative 
dot blot group IV support the reasoning that the dot blot 
detection limit might not be ideal for minimal IgE quan-
tification. Overall, the dot blot data suggest that sensitisa-
tion to cashew nut is not always correlated with a general 
sensitisation to multiple members of the Anacardiaceae 
family as only half of patients displaying sIgE to cashew 
nut protein were co-sensitised towards either pistachio, 
mango, pink peppercorn, or sumac (group I and III vs. 
group II). There is a possibility that the sensitisation pro-
files of the tested patients might slightly differ when test-
ing processed nuts. However, we expect that a mono-sen-
sitisation for cashew nut (group II) will be distinguishable 
from a multi-sensitisation profile (group I and group III 
Cashew
Control Serum group III
Bromelain
Ascorbate oxidase
Fig. 5. CCD sensitisation of patient group III. Dot blot immuno-
stainings of cashew nut, bromelain, and ascorbate oxidase spotted 
in duplicate and incubated with TBS (control) or serum pool of 
patient group III.
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patients) regardless of whether proteins are extracted 
from raw or processed nuts.
Whether the observed co-sensitisation in patients has 
been the result of independent sensitisation to multiple 
foods versus true cross-reacting proteins was further in-
vestigated using Western blotting for the Anacardiaceae 
species in group I and group III patients. Patients within 
group I merely showed IgE sensitisation to allergenic 2S 
albumins and/or 11S globulins in cashew nut, pistachio, 
and pink peppercorn, but not to any of the 7S vicilin al-
lergens. The absence of vicilin-sIgE in these patients 
could explain the observed low co-sensitisation to other 
tree nuts, as Ana o 1 is deemed to be the responsible cross-
reactive factor between different tree nuts [12–16]. Sur-
prisingly, ribulose-1,5-bisphosphate carboxylase oxygen-
ase (rubisco) in cashew nut, pistachio and pink pepper-
corn protein fractions was specifically detectable by this 
patient group I. Additionally, for these same patients pep-
tide homologs of the cross-reactive luminal BiP from C. 
avellana pollen [46] were recovered from the ca. 73–76 
kDa IgE-reactive protein bands in cashew and pistachio 
nut. Rubisco has been suggested as an allergen in spinach, 
tomato, and cannabis [47, 48], and additional putative 
BiP allergens have been identified in cannabis seed [48] 
and chickpea [49]. The clinical relevance of IgE-reactive 
rubisco and/or BiPs proteins for a cashew or pistachio nut 
allergy, also in relation to cross-reactivity towards tree 
nuts and stability during heat processing, has yet to be 
elucidated.
Multiple 11S globulin bands in cashew nut (Ana o 2), 
pistachio (Pis v 2/5), and pink peppercorn were recog-
nised by group III patients as well as 2S albumins (Ana o 
3, Pis v 1) and a 7S vicilin (Pis v 1). The diversity of such 
IgE reactivity might relate to the multiple tree nut sensi-
tisation profiles seen on dot blot for this patient group. 
Cross-reactivity between inhalant and food allergens 
likely plays an important role in this multi-food sensitised 
group and most likely accounts for the observed extensive 
cross-sensitisation patterns.
Despite the non-reactivity of group I patients to man-
go protein on dot blot, tentative chitinases and β-1,3-
glucanases from mango [50], both pathogenesis-related 
proteins found to be allergenic in multiple fruits and 
seeds [51, 52], were recognised by both patient groups on 
Western blot. Such differences between results might be 
due to differences in methodology used between the dot 
blot and Western blot techniques. However, part of the 
observed chitinase IgE reactivity was slightly biased by 
weak unspecific antibody-binding activity as concluded 
from the WB control. Although mango can cause severe 
anaphylactic reactions [30, 53, 54], immediate or delayed 
type manifesting hypersensitivity reactions to mango are 
distinctly rare [50] and most patients within our study 
had negative SPT results to this fruit. Furthermore, in a 
follow-up study using a small subset of the IDEAL patient 
cohort [21], 18 of 29 patients sensitised to cashew and 
pistachio nut, already consumed mango without symp-
toms, while the remaining 11 responded negative in an 
open food challenge with mango. Thus, despite observed 
IgE cross reactivity with cashew nut in our Western blots, 
both allergen types are seemingly not clinically relevant.
Inhibition Western blotting revealed considerable, 
and patient group-independent, cross-reactivity between 
cashew and pistachio nut, mango, and pink peppercorn. 
Cross-reactivity between cashew nut, pistachio, and pink 
peppercorn was expected because of the high cross-reac-
tive nature of seed storage proteins. However, for the 
mango IgE-reactive bands, this was rather unexpected as 
cashew is not known to contain any allergenic chitinases 
or β-1,3-glucanases. In addition, also several high mo-
lecular weight bands were detected in the mango sample 
for both patient groups which were absent on the inhibi-
tion Western blot, suggesting cross-reactivity. Unfortu-
nately, we were unable to identify these bands by LC-MS/
MS. Individual bands were indistinguishable and could 
not be excised from the SDS gel. CCD sensitisation in pa-
tients as visualised for group III patients (Fig. 5) might 
explain the observed mango-cashew co-sensitisation as 
approximately one-fifth of patients with an allergy seem 
to develop antibodies against CCDs with low clinical sig-
nificance [55]. In the inhibition Western blot for group I 
patients, an additional band ca. 13 kDa in size was no-
ticed, which was not detected in the normal immunoblot. 
Possibly, IgE antibodies were prevented from binding to 
this low allergenic band by blocking factors present in the 
serum pool that were eliminated in the inhibition experi-
ment. Based on the observation that cashew protein was 
able to completely inhibit IgE-binding to proteins from 
related species, we conclude that, in the patient group 
studied, cashew nut must be the primary sensitising 
agent.
To conclude, our results show that a large proportion 
of patients with a cashew nut allergy are IgE sensitised to 
multiple other Anacardiaceae species and/or tree nut spe-
cies. Using immunoblotting, we have identified putative 
cross-reactive allergens and/or allergens underlying ca-
shew sensitisation in young children. These putative nov-
el allergens, which were identified in cashew nut, pista-
chio, and pink peppercorn justify further prospective 
studies to determine and understand their clinical rele-
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vance and to develop effective immunotherapy strategies 
to treat or prevent cashew nut sensitisation in young chil-
dren.
Furthermore, cashew nut-allergic children with co-
sensitisation to pink peppercorn and sumac spice should 
precautionary exclude these foods from the diet to de-
crease potential risks of unwanted allergic reactions. In 
the absence of protocols for DBPCFs with pink pepper-
corn and sumac spice, the clinical relevance of these sen-
sitisations remains unclear.
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